The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-1-(8-chloro-2-(trifluoromethyl)benzofuro[3,2-d]pyrimidin-4-yl)-N-methylpyrrolidin-3-amine ID: ALA1092543
PubChem CID: 46885241
Max Phase: Preclinical
Molecular Formula: C16H14ClF3N4O
Molecular Weight: 370.76
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN[C@@H]1CCN(c2nc(C(F)(F)F)nc3c2oc2ccc(Cl)cc23)C1
Standard InChI: InChI=1S/C16H14ClF3N4O/c1-21-9-4-5-24(7-9)14-13-12(22-15(23-14)16(18,19)20)10-6-8(17)2-3-11(10)25-13/h2-3,6,9,21H,4-5,7H2,1H3/t9-/m1/s1
Standard InChI Key: WBBJYCNZUHEQHO-SECBINFHSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
16.7928 -8.4893 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.7786 -7.5122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7774 -8.3391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4918 -8.7518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4900 -7.0997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2049 -7.5086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2098 -8.3391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0013 -8.5911 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.9934 -7.2473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4832 -7.9155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3048 -7.8246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6376 -7.0661 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.1427 -6.3977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3228 -6.4921 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.0644 -7.1001 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
16.4709 -5.6414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5413 -9.2714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2108 -9.7529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8755 -9.2649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6167 -8.4819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6609 -9.5157 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.8364 -10.3213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2900 -5.5474 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
15.9800 -4.9790 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
16.8776 -4.9221 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12 13 1 0
3 4 1 0
13 14 2 0
14 9 1 0
11 1 1 0
4 7 2 0
2 15 1 0
7 8 1 0
13 16 1 0
1 17 1 0
8 10 1 0
9 6 1 0
2 3 2 0
6 5 2 0
17 18 1 0
18 19 1 0
19 20 1 0
20 1 1 0
9 10 2 0
19 21 1 6
5 2 1 0
21 22 1 0
10 11 1 0
16 23 1 0
6 7 1 0
16 24 1 0
11 12 2 0
16 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 370.76Molecular Weight (Monoisotopic): 370.0808AlogP: 3.85#Rotatable Bonds: 2Polar Surface Area: 54.19Molecular Species: BASEHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.49CX LogP: 4.32CX LogD: 2.26Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.74Np Likeness Score: -1.26
References 1. Cramp S, Dyke HJ, Higgs C, Clark DE, Gill M, Savy P, Jennings N, Price S, Lockey PM, Norman D, Porres S, Wilson F, Jones A, Ramsden N, Mangano R, Leggate D, Andersson M, Hale R.. (2010) Identification and hit-to-lead exploration of a novel series of histamine H4 receptor inverse agonists., 20 (8): [PMID:20299215 ] [10.1016/j.bmcl.2010.02.097 ]